Chronic migraine long-term regular treatment with onabotulinumtoxinA: a retrospective real-life observational study up to 4 years of therapy

INTRODUCTION: OnabotulinumtoxinA (BoNT-A) was proved effective and safe in chronic migraine (CM) prevention by the Phase III Research Evaluating Migraine Prophylaxis (PREEMPT) and Phase IV Chronic migraine OnabotulinuMtoxinA Prolonged Efficacy open-Label (COMPEL) trials over 1 and 2 years of treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoro, Antonio, Copetti, Massimiliano, Miscio, Anna M., Leone, Maurizio A., Fontana, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359167/
https://www.ncbi.nlm.nih.gov/pubmed/32052306
http://dx.doi.org/10.1007/s10072-020-04283-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359167/
https://www.ncbi.nlm.nih.gov/pubmed/32052306
http://dx.doi.org/10.1007/s10072-020-04283-y

Ejemplares similares